Kevin Muir

CIK: 0001929335

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DCTH

DELCATH SYSTEMS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

DCTH
DELCATH SYSTEMS, INC.
Feb 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
56.5K shares-
DCTH
DELCATH SYSTEMS, INC.
Feb 17, 2026
Award(A)
Restricted Stock Units
Direct
28.3K shares-
DCTH
DELCATH SYSTEMS, INC.
Feb 7, 2025
Award(A)
Stock Option (Right to Buy)
Direct
113K shares-

		Type	Shares	Price		Ownership
Feb 17, 2026	DCTH DELCATH SYSTEMS, INC.	Award(A) Stock Option (Right to Buy)	56,500	-	-	Direct
Feb 17, 2026	DCTH DELCATH SYSTEMS, INC.	Award(A) Restricted Stock Units	28,250	-	-	Direct
Feb 7, 2025	DCTH DELCATH SYSTEMS, INC.	Award(A) Stock Option (Right to Buy)	113,000	-	-	Direct

1-3 of 3 transactions

About Muir Kevin

Muir Kevin (SEC CIK 0001929335) files insider reports with the SEC as GM INTERVENTIONAL ONCOLOGY of DELCATH SYSTEMS, INC. (DCTH).

Signal8 holds 2 ownership filings by Muir Kevin, all Form 4s, filed between Feb 7, 2025 and Feb 18, 2026. Those filings report 3 transactions, from Feb 7, 2025 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Muir Kevin's filings is in QUEENSBURY, NY.

Recent filings by Muir Kevin

Feb 17, 2026: Grants or awards of DCTH derivative securities (2 lines, Form 4, code A).
Feb 7, 2025: Grant or award of DCTH derivative securities (Form 4, code A).

Other insiders filing for DELCATH SYSTEMS, INC. (DCTH)

How to read Form 4 transaction codes